Fanconi anemia in Ashkenazi Jews

Familial Cancer

Volumn 3, Issue 3-4, 2004, Pages 241-248

  Kutler, David ^a   Auerbach, Arleen ^b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

BRCA2; cancer predisposition; congenital malformation syndrome; FANCA; FANCC; Fanconi anemia; Jewish genetic disease

Indexed keywords

ANDROGEN; GRANULOCYTE COLONY STIMULATING FACTOR;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER SUSCEPTIBILITY; CLINICAL FEATURE; ETHNOLOGY; FANCONI ANEMIA; GENE ISOLATION; GENE MUTATION; GENETIC COMPLEMENTATION; GENETIC DISORDER; GENETIC HETEROGENEITY; GENOTYPE PHENOTYPE CORRELATION; HIRSUTISM; HUMAN; JEW; LIVER ADENOMA; PRIORITY JOURNAL;

CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FANCONI ANEMIA; FEMALE; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE DETECTION; HUMANS; INCIDENCE; JEWS; MALE; MUTATION; PEDIGREE; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 8544271687     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-004-9565-8     Document Type: Article

References (44)

1. Verlander PC, Kaporis A, Liu Q et al. Carrier frequency of the IVS4 + 4A > T mutation of the Fanconi anemia gene FAC in the Ashkenazi Jewish population. Blood 1995; 86: 4034-8.
2. Levran O, Erlich T, Magdalena N et al. Sequence variation in the Fanconi anemia gene FAA. Proc Natl Acad Sci USA. 1997; 94(24): 13051-6.
3. Neuhausen S, Gilewski T, Norton L et al. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat Genet 1996; 13: 126-8.
4. Auerbach AD, Buchwald M, Joenje H. Fanconi Anemia. In Vogelstein B, Kinzler, KW (eds). The Genetic Basis of Human Cancer, 2nd edition. New York: McGraw-Hill 2002; 289-306.
5. Butturini A, Gale RP, Verlander PC et al. Hematologic abnormalities in Fanconi anemia. An International Fanconi Anemia Registry study. Blood 1994; 84: 1650-5.
6. Giampietro PF, Adler-Brecher B, Verlander PC et al. The need for more accurate and timely diagnosis in Fanconi anemia. A report from the International Fanconi Anemia Registry. Pediatr 1993; 91: 1116-20.
7. Giampietro PF, Verlander PC, Davis JG et al. Diagnosis of Fanconi anemia in patients without congenital malformations: an International Fanconi Anemia Registry study. Am J Med Genet 1996; 68: 58-61.
8. Kutler DI, Singh B, Satagopan J et al. A 20 year perspective of The International Fanconi Anemia Registry (IFAR). Blood 2003; 101: 1249-56.
9. Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood 2003; 101(3): 822-6.
10. Auerbach AD. Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp Hematol 1993; 21: 731-3.
11. Auerbach AD. Diagnosis of Fanconi anemia by diepoxybutane analysis. In Dracopoli NC, Haines JL, Korf BR et al. (eds): Current Protocols in Human Genetics. New York: John Wiley & Sons 2003; Supplement 37, 8.7.1-8.7.15.
12. Verlander PC, Shin HT, Auerbach AD. Haplotype analysis of polymorphic markers surrounding the Fanconi anemia gene FAC: evidence for a founder effect for the IVS4 + 4A > T mutation. Am J Hum Genet 1995; 57: A174. [abstract].
13. Joenje H, Oostra AB, Wijker M et al. Evidence for at least eight Fanconi anemia genes. Am J Hum Genet 1997; 61(4): 940-4.
14. Hanenberg H, Batish SD, Pollok KE et al. Phenotypic correction of primary Fanconi anemia T cells with retroviral vectors as a diagnostic tool. Exp Hematol 2002; 30: 410-20.
15. Maatei AR, de Winter JP, Medhurst AL et al. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet 2003; 35: 165-70.
16. Levitus M, Rooimans MA, Steltenpool J et al. Heterogeneity in Fanconi anemia: evidence for two new genetic subtypes. Blood 2003; Nov 20 [Epub ahead of print].
17. Yamashita T, Wu N, Kupfer G et al. Clinical variability of Fanconi anemia (type C) results from expression of an amino terminal truncated Fanconi anemia complementation group C polypeptide with partial activity. Blood 1996; 87: 4424-32.
18. Gillio AP, Verlander PC, Batish SD et al. Phenotypic consequences of mutations in the Fanconi anemia FAC gene: an International Fanconi Anemia Registry study. Blood 1997; 90: 105-10.
19. D'Andrea AD, Grompe M. The Fanconi anaemia/BRCA pathway. Nat Rev Cancer 2003; 1: 23-34.
20. Joenje H, Patel KJ. The emerging genetic and molecular basis of Fanconi anaemia. Nat Rev Genet 2001; 6: 446-57.
21. Strathdee CA, Gavish H, Shannon WR, Buchwald M. Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature 1992; 356: 763-7 [published erratum appears in Nature 1992; 358: 434].
22. Strathdee CA, Duncan AM, Buchwald M. Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9. Nat Genet 1992; 1: 196-8.
23. Savoia A, Centra M, Ianzano L et al. Characterization of the 5′ region of the Fanconi anemia group C (FACC) gene. Hum Mol Genet 1995; 4: 1321-6.
24. Whitney MA, Saito H, Jakobs PM et al. A common mutation in the FACC gene causes Fanconi anaemia in Ashkenazi Jews. Nat Genet 1993; 4: 202-5.
25. Verlander PC, Lin JD, Udono MU et al. Mutation analysis of the Fanconi anemia gene FACC. Am J Hum Genet 1994; 54: 595-601.
26. Gibson RA, Morgan NV, Goldstein LH et al. Novel mutations and polymorphisms in the Fanconi anaemia group C gene. Hum Mutat 1996; 8: 140-8.
27. Lo Ten Foe JR, Barel MT, Thuss P et al. Sequence variations in the Fanconi anaemia gene, FAC: pathogenicity of 1806insA and R548X and recognition of D195V as a polymorphic variant. Hum Genet 1996; 98: 522-3.
28. Lo Ten Foe JR, Rooimans MA, Bosnoyan-Collins L et al. Expression cloning of a cDNA for the major Fanconi anemia gene, FAA. Nat Genet 1996; 14: 320-3.
29. Fanconi Anaemia/Breast Cancer Consortium. Positional cloning of the Fanconi anaemia group A gene. Nat Genet 1996; 14: 324-8.
30. Hewlett NG, Taniguchi T, Olson S et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 2002; 297: 606-9.
31. Wagner JE, Tolar J, Levran O et al. Germline Mutations in BRCA2: Shared Genetic Susceptibility to Breast Cancer, Early Onset Leukemia and Fanconi Anemia. Blood 2004; Jan 8 [Epub ahead of print].
32. Hirsch B, Shimamura A, Moreau L et al. Biallelic BRCA2/FANCD1 mutations: association with spontaneous chromosomal instability and solid tumors of childhood. Blood 2003; Dec 11 [Epub ahead of print].
33. Offit K, Levran O, Mullaney B et al. Shared Genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia in an extended family. J Natl Cancer Inst 2003; 95: 1548-51.
34. Oddoux C, Struewing JP, Clayton CM et al. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet 1996; 14(2): 188-90.
35. National Human Genome Research Insitute (NHGRI). An open access on-line breast cancer mutation database: an international collaborative effort hosted by NHGRI. Retrieved from http:// research.nhgri.nih.gov/bic/ on 18 August 2003.
36. Mazoyer S, Dunning AM, Serova O et al. A polymorphic stop codon in BRCA2. Nat Genet 1996; 14(3): 253-4.
37. Kauff ND, Perez-Segura P, Robson ME et al. Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families. J Med Genet 2002; 39(8): 611-4.
38. Wajnrajch MP, Gertner JM, Huma Z et al. Evaluation of growth and hormonal status in patients referred to the International Fanconi Anemia Registry. Pediatrics 2001; 107: 744-54.
39. Wagner JE, MacMillan ML, Auerbach AD. Hematopoietic cell transplantation in the treatment of Fanconi anemia. In Forman SJ, Blume KG, Thomas ED (eds): Hematopoietic Cell Transplantation, 3rd edition. Malden: Blackwell Science 2003; 1483-4.
40. Auerbach AD, Liu Q, Ghosh R et al. Prenatal identification of potential donors for umbilical cord blood transplantation for Fanconi anemia. Transfusion 1990; 30: 682-7.
41. Auerbach AD. Umbilical cord blood transplants for genetic disease: diagnostic and ethical issues in fetal studies. Blood Cells 1994; 20: 303-9.
42. Verlinsky Y, Rechitsky S, Schoolcraft W et al. Preimplantation diagnosis for Fanconi anemia combined with HLA matching. JAMA 2001; 285: 3130-3.
43. Grewal SS, Kahn JP, MacMillan ML et al. Successful hematopoietic stem cell transplantation for Fanconi anemia from an unaffected HLA-genotype- identical sibling selected using preimplantation genetic diagnosis. Blood 2004; 103: 1147-51.
44. Wolf SM, Kahn JP, Wagner JE. Using preimplantation genetic diagnosis to create a stem cell donor: issues, guidelines & limits. J Law Med Ethics 2003; 31(3): 327-39.